Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastrointestinal Cancers
•
Medical Oncology
Which adjuvant chemotherapy would you offer to a MSI high pancreatic cancer patient after Whipple?
Answer from: Medical Oncologist at Community Practice
Not yet ready for IO alone. Can add IO to FFX maybe.
Sign In
or
Register
to read more
20162
Related Questions
Which PD-1 inhibitor will you use with chemotherapy in initial treatment of patients with metastatic anal cancer?
Given that ESOPEC did not mandate PET staging, are the conclusions of the study still applicable for patients who are staged with PET?
What is your institutional practice for neoadjuvant therapy prior to transplanting cholangiocarcinoma?
How do you plan to integrate exercise programs after adjuvant chemotherapy in patients with colon cancer, given the results of the CHALLENGE trial?
Is there a role for stents for patients with new diagnosis of metastatic upper rectal cancer with near obstructing primary?
What patients with new onset diabetes require imaging of the pancreas?
Which patients, if any, treated according to PROSPECT for an early stage rectal cancer, would you offer surveillance if they achieved cCR after neoadjuvant chemotherapy?
In pts with HCC who initially achieved a good response on durvalumab/tremelimumab , but later lost it, would you consider rechallenging with tremelimumab ?
Under what circumstances do you give chemotherapy for a nondiagnostic pancreas biopsy that is suspicious for adenocarcinoma?
What factors would make you choose IPI3/NIVO1 frontline for advanced unresectable and metastatic HCC based on CheckMate 9DW?